oops, I didn't realize the earning when I wrote
the last post.
The headline is misleading but
the realease is positive (for true longs). They
basically took the one-time charge under the pretext of the
change of accounting principle and they can afford to do
that before the BNBN IPO to minimize price fluctuation
Sales is up and they closed more
brick-mortar store which are not bringing significant revenue.
The tricky part is that we don't know how the street
will look at this earning. Stock price may show
uncertainty in the early trading session tomorrow, but that's
the best time to get some bargins if it
Yes you will see 50-60 on the first day of BNBN
IPO and this will bring BKS's valuation up. That is
the reason why many people (back door players) are
putting money in BKS right now. There is a possibility
that BKS goes to 70+ pre-IPO or right after IPO; but
it's unlikely by looking at the volume
I have lots of stake in BKS right now. VRTL have
changed me to become a position players from a long-term
investor and I am not concerned about recent down trend
with BKS considering the volatility I took from VRTL.
In my personal opinion, BKS trading price today
below $33 is a screaming buy.
Hal-Witt has done
an excellent job on BKS share prices analysis,
follow the link, and you will find more. I will post
another post to re-cap the events we are expecting in the
Drugstore.com Files to Raise $67.5 Mln Through
Washington, May 19 (Bloomberg)
-- Drugstore.com Inc., an online retailer of drugs
products that is backed by
Amazon.com Inc., filed for an initial stock sale that could
raise as much as
Bellevue, Washington-based company was formed last year and
started selling products in
is led by former Microsoft Corp. executive Peter
Neupert, 43, and counts
venture capital firm Kleiner
Perkins Caufield & Byers as well as Microsoft co-founder
Vulcan Ventures Inc. and Starbucks
Corp. Chairman Howard Schultz among its top
Amazon.com, the online retailer of books and
music, holds a 43.8 percent stake before the
Staking out a place in the online medicine and
personal-care market could be big business: Total
sales of drugs, vitamins and personal-care products
will reach $180 billion this year, estimates
Husson, a Merrill Lynch analyst. That's almost five times
the $38.5 billion in total sales Forrester
Research Inc. projects this year for books and music, two
of the most successful online categories.
Drugstore.com and other startups, including CVS's Corp.'s newly
purchased Soma.com, PlanetRX
Inc. and RX.com, are
betting they can win over a lot of busy bargain hunters.
They say the
convenience of buying online also
will help them tap the growing demand for health-care
from an aging U.S. population.
prescription business is especially appealing. Surging sales
to older consumers helped boost
sales 15 percent last year to $102.5 billion, according
to the National Association of
Stores. That makes prescriptions one of the
fastest-growing parts of U.S. retailing.
posted a $10.2 million net loss in the quarter ended
April 4 on sales of $652,000, its
selling drugs and prescription, beauty and health
products on line.
Drugstore.com said it may use
proceeds from the stock sale to make acquisitions. The
decided to go public in part to ``to increase our
working capital'' and to ``increase our visibility in
retail marketplace,'' according to a filing with
the Securities and Exchange Commission.
Drugstore.com didn't specify the number of shares it would sell
or their estimated price range. Those
will be included in a supplemental filing. The $67.5
million top value was used solely to
An underwriting group led by Morgan
Stanley Dean Witter will market shares to the public.
Drugstore.com has applied to trade on the Nasdaq Stock Market
under the symbol ``DSCM.''
Checked chart w/Clear Station. Last 2 major
run-ups of BKS took only 3 days. Late June '98 and late
Dec '98. June volume prior to run-up was smaller than
current volume. Dec '98 volume a bit more. Seems that BKS
can't be viewed as typical stock regardless of IPO
news. Don't totally buy into MM as reason but something
is up with this stock...but 3 day run-up past
performance looks like this Thurs, Fri. and Monday to me.
Tomorrow with earnings report the BIG day? Anyone have a
target for tomorrow if earnings are acceptable to
Thanks for your reply on the DSET board. Someone
had a calculation on BKS of $30 + 80% of BNBN's price
at IPO. Based on your BNBN price of $50 - $60 this
would work out to a $74 price for BKS. Does this make
any sense? If so, how soon after May option
I hope you bought June options instead of May.
I'm 75% May 35s and, 25% June 40s. Oh well, the MMs
aren't getting my cherry, that got popped long
Good Luck All !!!!!!!!!!!! we may need it
Nice big blocks right at the end of the
Steve Frank just mentioned on CNBC about AMZN's mixed
debt offering and how they might be doing it to steal
BKS's thunder with the upcoming ipo.
hoping for something good this week. Go
Through the vertical integration of Ingram, and
the leveraging of its existing billing
infrastructure, BKS will have a significant pricing advantage
over competitors. Amazon's price slashing is a cheap
PR stunt that smells like fear. Sooner or later
Amazon will have to address poor profit margins in the
face of mounting debt. When that happens you can kiss
these pseudo-hardball tactics goodbye. If it's customer
base and revenue growth you're looking for (the only
thing that supports Amazons absurd valuation) you will
not be disappointed. Bertelsmann is a 600 pound
multi-media gorilla. Once it starts throwing its weight
around BKS will blow by amazon. Amazon can't sustain its
marketing blitz forever, BKN has yet begun to fight. Any
Questions? Buy and hold BKN, you won't be disappointed.
For chrissakes -
is thing going to make it to
38 or will i have to sell at 36 just to save my ass
- what a weird stock - i know there are no
guarantees, but this baby is being controlled by somebody -